论文部分内容阅读
目的:探究双倍剂量氨溴索口服液治疗糖尿病合并社区获得性肺炎的疗效及安全性。方法:抽取2012年6月到2013年7月在我院就诊的2型糖尿病合并社区获得新肺炎患者66例,随机分为观察组与对照组,各为33例。以常规糖尿病治疗与对症处理为基础,进入对对照组患者实施常规剂量氨溴索口服液,口服,每日3次,1次1袋,每袋30mg×10ml;同时采用2g的头孢替安溶于0.9%氯化钠注射液250毫静脉滴注,每日滴注一次。对观察组实施氨溴索口服液,口服,每日3次,1次2袋;同时采用2g的头孢替安溶于0.9%氯化钠注射液250毫静脉滴注,每日滴注一次。两组患者治疗时长均为7天,观察两组患者治疗后的各项指标。结果:经治疗后,观察组各项指标明显优于对照组,两组数据差异明显(P<0.05)。结论:对于糖尿病合并社区获得新肺炎,采用双倍剂量氨溴索口服液进行治疗,其效果明显,且对患者血糖水平没有影响,值得在临床中推广及使用。
Objective: To investigate the efficacy and safety of double-dose ambroxol oral solution in the treatment of diabetic patients with community-acquired pneumonia. Methods: Sixty-six patients with newly diagnosed pneumonia who were admitted to our hospital from June 2012 to July 2013 for type 2 diabetes were randomly divided into observation group and control group, with 33 cases in each. Taking routine diabetes treatment and symptomatic treatment as the foundation, the patients in the control group were enrolled in the routine dose of ambroxol orally, orally once daily for 3 times, one time for 1 bag, 30mg × 10ml per bag. At the same time, 2g cefotiam In 0.9% sodium chloride injection of 250 milligrams intravenously drip once a day. Ambroxol orally administered to the observation group, orally, 3 times a day, 1 2 bags; the same time with 2g of cefotiam dissolved in 0.9% sodium chloride injection of 250 milliliters intravenous drip once a day. The two groups of patients were treated for a duration of 7 days, the two groups were observed after treatment of the indicators. Results: After treatment, the indicators in the observation group were significantly better than those in the control group, with significant differences between the two groups (P <0.05). CONCLUSIONS: For patients with diabetes mellitus and community acquired new pneumonia, double-dose ambroxol oral solution has obvious effect and has no effect on blood glucose level of patients. It is worth to be popularized and used clinically.